COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 1917: Articles 19161-19170  | Next

A Community-Based Participatory Research to Assess the Feasibility of Ayurveda Intervention in Patients with Mild-to-Moderate COVID-19
Kulkarni, V., Sharma, N., Modi, D., Kumar, A., Joshi, J., Krishnamurthy, N.
10.1101/2021.01.20.21250198 — Posted: 2021-01-26
Variability in codon usage in Coronaviruses is mainly driven by mutational bias and selective constraints on CpG dinucleotide
Daron, J., Bravo, I. G.
10.1101/2021.01.26.428296 — Posted: 2021-01-26
40 minutes RT-qPCR Assay for Screening Spike N501Y and HV69-70del Mutations
Korukluoglu, G., Kolukirik, M., Bayrakdar, F., Ozgumus, G. G., Altas, A. B., Cosgun, Y., Ketre Kolukirik, C. Z.
10.1101/2021.01.26.428302 — Posted: 2021-01-26
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2
Vanshylla, K., Di Cristianziano, V., Kleipass, F., Dewald, F., Schommers, P., Gieselmann, L., Gruell, H., Schlotz, M., Ercanoglu, M. S., Stumpf, R., Mayer, P., Heger, E., Johannis, W., Horn, C., Suarez, I., Jung, N., Salomon, S., Eberhardt, K., Faetkenheuer, G., Pfeifer, N., Eggeling, R., Augustin, M., Lehmann, C., Klein, F.
10.1101/2021.01.26.428207 — Posted: 2021-01-26
Computational Investigation of Increased Virulence and Pathogenesis of SARS-CoV-2 Lineage B.1.1.7
Natarajan, M. A., S. Javali, P., Jeyaraj Pandian, C., Akhtar Ali, M., Srivastava, V., Jeyaraman, J.
10.1101/2021.01.25.428190 — Posted: 2021-01-26
Neutralization of UK-variant VUI-202012/01 with COVAXIN vaccinated human serum
Sapkal, G. N., Yadav, P., Ella, R., Deshpande, G., Sahay, R., Gupta, N., Mohan, V. K., Abraham, P., Panda, S., Bhargava, B.
10.1101/2021.01.26.426986 — Posted: 2021-01-26
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
Hassan, A. O., Feldmann, F., Zhao, H., Curiel, D. T., Okumura, A., Tang-Huau, T.-L., Case, J. B., Meade-White, K., Callison, J., Lovaglio, J., Hanley, P. W., Scott, D. P., Fremont, D. H., Feldmann, H., Diamond, M. S.
10.1101/2021.01.26.428251 — Posted: 2021-01-26
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization
Wang, P., Lihong, L., Iketani, S., Luo, Y., Guo, Y., Wang, M., Yu, J., Zhang, B., Kwong, P. D., Graham, B. S., Mascola, J. R., Chang, J. Y., Yin, M. T., Sobieszczyk, M. E., Kyratsous, C. A., Shapiro, L., Sheng, Z., Nair, M. S., Huang, Y., Ho, D. D.
10.1101/2021.01.25.428137 — Posted: 2021-01-26
Variant and mutation analysis of SARS-CoV-2 genomes isolated from the Kingdom of Bahrain
bindayna, K. M., Deifalla, A. H., Mokbel, H. E. M.
10.1101/2021.01.25.428191 — Posted: 2021-01-26
A novel SARS-CoV-2 related coronavirus in bats from Cambodia
Hul, V., Delaune, D., Karlsson, E. A., Hassanin, A., Ou Tey, P., Baidaliuk, A., Gambaro, F., Tu, V. T., Keatts, L., Mazet, J., Johnson, C., Buchy, P., Dussart, P., Goldstein, T., Simon-Loriere, E., Duong, V.
10.1101/2021.01.26.428212 — Posted: 2021-01-26 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).